Cargando…
MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant brain tumor, and there is no effective treatment strategy. Patients with GBM have a median overall survival of only 14.6 months. Current treatment consists of safe and maximal surgical excision, followed by concurrent chemoradiotherapy...
Autores principales: | Lee, Yi-Yen, Yarmishyn, Aliaksandr A, Wang, Mong-Lien, Chen, Hsiao-Yun, Chiou, Shih-Hwa, Yang, Yi-Ping, Lin, Chun-Fu, Huang, Pin-I, Chen, Yi-Wei, Ma, Hsin-I, Chen, Ming-Teh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903834/ https://www.ncbi.nlm.nih.gov/pubmed/29695934 http://dx.doi.org/10.2147/CMAR.S157261 |
Ejemplares similares
-
Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
por: Yarmishyn, Aliaksandr A., et al.
Publicado: (2020) -
Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression
por: Yang, Yi-Ping, et al.
Publicado: (2021) -
Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3
por: Chen, Hsiao-Yun, et al.
Publicado: (2017) -
Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
por: Liu, Wei-Hsiu, et al.
Publicado: (2015) -
The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma
por: Hsu, Chih-Yi, et al.
Publicado: (2017)